Page 1 of 1

MS therapies in pediatric patients with refractory MS

Posted: Tue Apr 12, 2011 12:17 am
by MSUK
Image


Background: Currently available disease-modifying therapies (DMTs) are known to be only partially effective in adults with multiple sclerosis (MS). Little is known about pediatric patients with MS who experience refractory disease while receiving first-line DMTs.

Objective

To assess the occurrence and management of refractory disease in a group of pediatric patients with MS treated with first-line DMTs approved for adult patients within a network of pediatric MS centers in the United States.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1408